DEXILANT 60 MG CAP DURA LIB RETARD CT BL AL AL X 60
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1063902610086 -
GGREM
501112070019802 -
Código de barras
7896641809033
O que a fonte publica
- Detentor do registro
- TAKEDA PHARMA LTDA.
- Princípios ativos
- DEXLANSOPRAZOL
- Embalagem
- 60 MG CAP DURA LIB RETARD CT BL AL AL X 60
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- A2B2 - INIBIDORES DA BOMBA DE PRÓTONS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "DEXILANT 60 MG CAP DURA LIB RETARD CT BL AL AL X 60",
"holder": "TAKEDA PHARMA LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896641809033"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "501112070019802",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "60.397.775/0001-74",
"priceRegime": "Regulado",
"productName": "DEXILANT",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "60 MG CAP DURA LIB RETARD CT BL AL AL X 60",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "164.68",
"icms-12": "187.14",
"icms-17": "198.41",
"icms-18": "200.83",
"icms-19": "203.31",
"icms-20": "205.85",
"icms-21": "208.46",
"icms-22": "211.13",
"icms-23": "213.87",
"icms-17.5": "199.61",
"icms-19.5": "204.57",
"icms-20.5": "207.14",
"icms-22.5": "212.49",
"icms-12-alc": "167.09",
"icms-17-alc": "177.15",
"icms-18-alc": "179.31",
"icms-19-alc": "181.53",
"icms-20-alc": "183.79",
"icms-21-alc": "186.12",
"icms-22-alc": "188.51",
"icms-23-alc": "190.96",
"withoutTaxes": "147.04",
"icms-17.5-alc": "178.23",
"icms-19.5-alc": "182.65",
"icms-20.5-alc": "184.95",
"icms-22.5-alc": "189.72"
},
"pisCofinsList": "Negativa",
"substanceText": "DEXLANSOPRAZOL",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "220.91",
"icms-12": "251.04",
"icms-17": "266.16",
"icms-18": "269.41",
"icms-19": "272.73",
"icms-20": "276.14",
"icms-21": "279.64",
"icms-22": "283.22",
"icms-23": "286.90",
"icms-17.5": "267.77",
"icms-19.5": "274.42",
"icms-20.5": "277.87",
"icms-22.5": "285.05",
"icms-12-alc": "230.99",
"icms-17-alc": "244.90",
"icms-18-alc": "247.89",
"icms-19-alc": "250.95",
"icms-20-alc": "254.08",
"icms-21-alc": "257.30",
"icms-22-alc": "260.60",
"icms-23-alc": "263.99",
"withoutTaxes": "203.27",
"icms-17.5-alc": "246.39",
"icms-19.5-alc": "252.50",
"icms-20.5-alc": "255.68",
"icms-22.5-alc": "262.28"
},
"invalidBarcodes": [],
"activeSubstances": [
"DEXLANSOPRAZOL"
],
"therapeuticClass": "A2B2 - INIBIDORES DA BOMBA DE PRÓTONS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1063902610086",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A2B2",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:501112070019802"